266
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

Immunotherapy in the Initial Treatment of Newly Diagnosed Cancer Patients: Utilization Trend and Cost Projections for Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, and Metastatic Colorectal Cancer

, , , &
Pages 46-53 | Published online: 08 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yin Wan, Xin Gao, Sonam Mehta, Zhixiao Wang, Claudio Faria & Lee Schwartzberg. (2013) Indirect costs associated with metastatic breast cancer. Journal of Medical Economics 16:10, pages 1169-1178.
Read now
Chun-Ru Chien & Ya-Chen Tina Shih. (2012) Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC). ClinicoEconomics and Outcomes Research 4, pages 201-208.
Read now

Articles from other publishers (12)

Rui He, Yefang Lao, Wenyan Yu, Xiaohui Zhang, Min Jiang & Chunrong Zhu. (2021) Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer. Frontiers in Oncology 11.
Crossref
Zahra Aryan, Mahsa Keshavarz-Fathi, Håkan Mellstedt & Nima Rezaei. 2020. Cancer Immunology. Cancer Immunology 1 48 .
Reith R Sarkar, Nicholas J Gloude, Deborah Schiff & James D Murphy. (2019) Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia. JNCI: Journal of the National Cancer Institute 111:7, pages 719-726.
Crossref
Kathryn R Tringale, Kate T Carroll, Kaveh Zakeri, Assuntina G Sacco, Linda Barnachea & James D Murphy. (2018) Cost-effectiveness Analysis of Nivolumab for Treatment of Platinum-Resistant Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. JNCI: Journal of the National Cancer Institute 110:5, pages 479-485.
Crossref
Jian Jian Li. 2017. Advances in Radiation Oncology. Advances in Radiation Oncology 191 221 .
Andrew C. Cannon & Fausto R. LoberizaJr.Jr.. (2015) Review of Antibody-Based Immunotherapy in the Treatment of Non-Hodgkin Lymphoma and Patterns of Use. Clinical Lymphoma Myeloma and Leukemia 15:3, pages 129-138.
Crossref
P F Forde, L J Hall, M de Kruijf, M G Bourke, T Doddy, M Sadadcharam & D M Soden. (2014) Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models. Gene Therapy 22:1, pages 29-39.
Crossref
Zahra Aryan, Håkan Mellstedt & Nima Rezaei. 2015. Cancer Immunology. Cancer Immunology 1 39 .
S Detchokul, E D Williams, M W Parker & A G Frauman. (2014) Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. British Journal of Pharmacology 171:24, pages 5462-5490.
Crossref
C H Ahern, Y-C T Shih, W Dong, G Parmigiani & Y Shen. (2014) Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. British Journal of Cancer 111:8, pages 1542-1551.
Crossref
Ya‐Chen Tina Shih & Benjamin D. Smith. 2012. Cancer and Aging Handbook. Cancer and Aging Handbook 475 485 .
Talia S. Foster, Jeffrey D. Miller, Mark E. Boye, Marissa B. Blieden, Risha Gidwani & Mason W. Russell. (2011) The economic burden of metastatic breast cancer: A systematic review of literature from developed countries. Cancer Treatment Reviews.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.